Harrow, Inc. revenue for the last year amounted to 130.19 M USD, the most of which — 130.19 M USD — came from its highest performing source at the moment, Innovative Ophthalmic Therapies, the year earlier bringing 88.59 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Harrow, Inc. 130.19 M USD, and the year before that — 88.59 M USD.